Loading... Please wait... Loading... Please wait...
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
Vakiener Victoriadirector |
Sell | 1,799 @ $23.31 | $41,935 | 30,205 | 05/02/2024 | 05/06/2024 | |
Hamilton James CChief Discovery/Trans Medicine |
Sell | 6,000 @ $28.03 | $168,180 | 204,851 | 04/01/2024 | 04/03/2024 | |
Lu Hongbodirector |
Buy | 1,000 @ $27.50 | $27,500 | 33,680 | 03/20/2024 | 03/20/2024 | |
Lu Hongbodirector |
Buy | 1,000 @ $28.00 | $28,000 | 32,680 | 03/19/2024 | 03/20/2024 | |
Lu Hongbodirector |
Buy | 1,000 @ $27.49 | $27,490 | 31,680 | 03/18/2024 | 03/20/2024 | |
Myszkowski Kenneth AllenCFO |
Sell | 40,000 @ $35.19 | $1.41 M | 400,600 | 03/06/2024 | 03/08/2024 | |
Anzalone Christopher RichardCEO |
Sell | 37,769 @ $32.16 | $1.21 M | 3,734,778 | 01/31/2024 | 02/02/2024 | |
Anzalone Christopher RichardCEO |
Sell | 19,730 @ $32.71 | $645,368 | 3,715,048 | 01/31/2024 | 02/02/2024 | |
Hamilton James CChief Discovery/Trans Medicine |
Sell | 4,238 @ $36.47 | $154,560 | 214,553 | 01/12/2024 | 01/17/2024 | |
Hamilton James CChief Discovery/Trans Medicine |
Sell | 3,702 @ $37.37 | $138,344 | 210,851 | 01/12/2024 | 01/17/2024 | |
GIVEN DOUGLAS Bdirector |
Sell | 1,811 @ $37.76 | $68,383 | 130,811 | 01/11/2024 | 01/16/2024 | |
GIVEN DOUGLAS Bdirector |
Sell | 1,100 @ $38.55 | $42,405 | 129,711 | 01/11/2024 | 01/16/2024 | |
Waddill William D.director |
Sell | 2,634 @ $37.81 | $99,592 | 49,170 | 01/11/2024 | 01/16/2024 | |
Waddill William D.director |
Sell | 1,300 @ $38.59 | $50,167 | 47,870 | 01/11/2024 | 01/16/2024 | |
Ferrari Maurodirector |
Sell | 2,147 @ $37.80 | $81,157 | 61,778 | 01/11/2024 | 01/16/2024 | |
Ferrari Maurodirector |
Sell | 1,000 @ $38.63 | $38,630 | 60,778 | 01/11/2024 | 01/16/2024 | |
Vakiener Victoriadirector |
Sell | 3,620 @ $37.87 | $137,089 | 33,101 | 01/11/2024 | 01/16/2024 | |
Vakiener Victoriadirector |
Sell | 1,100 @ $38.84 | $42,724 | 32,001 | 01/11/2024 | 01/16/2024 | |
Oliver TracieChief Commercial Officer |
Sell | 74 @ $33.89 | $2,508 | 136,501 | 01/05/2024 | 01/08/2024 | |
Myszkowski Kenneth AllenCFO |
Sell | 1,400 @ $34.04 | $47,656 | 455,304 | 01/05/2024 | 01/08/2024 |
| Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
|---|
A. The list of insiders at Arrowhead Pharmaceuticals, Inc. includes Anzalone Christopher Richard, Vakiener Victoria, San Martin Javier, O'Brien Patrick, Hamilton James C, Myszkowski Kenneth Allen, Oliver Tracie, Ferrari Mauro, Waddill William D., GIVEN DOUGLAS B, Lu Hongbo.
A. Insiders have sold a total of 349,359 Arrowhead Pharmaceuticals, Inc. shares in the last 12 months for a total of 11.14 M sold.
A. The following insiders have sold Arrowhead Pharmaceuticals, Inc. shares in the last 12 months: Anzalone Christopher Richard ($4.72 M), Vakiener Victoria ($262,560), San Martin Javier ($860,119), O'Brien Patrick ($1.14 M), Hamilton James C ($1.79 M), Myszkowski Kenneth Allen ($1.98 M), Oliver Tracie ($2,508), Ferrari Mauro ($119,787), Waddill William D. ($149,759), GIVEN DOUGLAS B ($110,788),
A. Insiders have purchased a total of 3,000 Arrowhead Pharmaceuticals, Inc. shares in the last 12 months for a total of 82,990 sold.
A. The following insiders have purchased Arrowhead Pharmaceuticals, Inc. shares in the last 12 months: Lu Hongbo ($82,990),
